The spread of the Mpox virus in the Indian Ocean has just reached a new stage. A first case has been confirmed in Réunion in a resident who recently returned from Madagascar. The announcement, made Thursday by the Regional Health Agency, marks the official entry of Réunion into the enhanced vigilance zone, while the disease had already been circulating for several weeks in the region, particularly in Mayotte and Madagascar.
According to health authorities, the individual in question developed symptoms after returning to the island, ruling out, at this stage, infection during the flight. They were immediately placed in isolation to limit any risk of transmission. Identified close contacts are under close medical monitoring, in conjunction with the University Hospital of Réunion, to quickly detect any potential clinical signs and break any chain of transmission.
Increased vigilance is needed in the face of a virus already present in the area.
The emergence of this first case did not come as a complete surprise to the authorities. As soon as Mpox outbreaks were identified in Madagascar, the Regional Health Agency, in coordination with national health authorities, had anticipated the risk of importation. Preventive measures had been put in place, based in particular on informing healthcare professionals and strengthening border surveillance for travelers to and from the affected areas.
The stated objective is clear: to enable rapid identification of suspected cases and early intervention, in order to prevent local spread of the virus. Health officials reiterate that the situation remains under control and that no active circulation of Mpox has been observed at this stage in Réunion, apart from this imported case.
Health authorities are urging the public to remain vigilant, especially those who have recently traveled to Madagascar. Any appearance of suggestive symptoms, such as fever, body aches, headaches, or a rash, should prompt a prompt medical consultation and self-isolation until professional advice is received. This precaution aims to protect those around the infected individual and prevent community transmission.
Understanding Mpox and limiting the risks of transmission
Mpox, formerly known as monkeypox, is an infectious disease caused by the monkeypox virus. It most often manifests as a rash that can affect various parts of the body, including the face, extremities, or anogenital region. These lesions may be itchy and preceded or accompanied by general symptoms such as fever, headache, muscle aches, or swollen lymph nodes. The incubation period typically ranges from five to twenty-one days.
Human-to-human transmission relies primarily on direct contact with the skin lesions or mucous membranes of an infected person, as well as indirect contact with contaminated objects, such as linens or dishes. Transmission via respiratory droplets remains marginal and requires prolonged close contact, which explains why wearing a mask is mainly recommended for sick individuals. Isolation and covering lesions are the most effective measures to limit the spread of the virus.
The illness usually resolves favorably, with an average duration of two to three weeks. Contagiousness begins with the appearance of the first symptoms and continues until the skin lesions have completely healed. This is why a period of isolation of at least three weeks is generally recommended.
In this context, the authorities also remind the public that a vaccine is available, and that its suitability can be assessed by a doctor, particularly before traveling to an area where the virus is actively circulating. A national information hotline dedicated to Mpox remains available to answer public questions and guide those affected.
With this first confirmed case, Réunion Island enters a phase of heightened surveillance. Health authorities are emphasizing the need for collective action, based on information, individual responsibility, and the responsiveness of the healthcare system, to contain the virus and prevent it from becoming established in the territory.
